Synchron Stock, Valuation, and IPO Potential
Thanks to its wealthy founder, Neuralink gets most of the brain-computer interface (BCI) news coverage. But an Australian/U.S.-based company is further along the FDA approval process, and its device is less intrusive than its competitors.